Price Alert

Icosavax Inc. (ICVX)

NASDAQ: ICVX · Real-Time Price · USD

15.31

-0.14 (-0.91%)

At close: Feb 16, 2024, 10:00 PM

Icosavax Statistics

Share Statistics

Icosavax has 50.23M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	50.23M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	29.3M
Failed to Deliver (FTD) Shares	1,030
FTD / Avg. Volume	0.1%

Short Selling Information

The latest short interest is 289.43K, so 0.58% of the outstanding shares have been sold short.

Short Interest	289.43K
Short % of Shares Out	0.58%
Short % of Float	0.97%
Short Ratio (days to cover)	1

Valuation Ratios

The PE ratio is -3.57 and the forward PE ratio is null. Icosavax's PEG ratio is 0.09.

PE Ratio	-3.57
Forward PE	n/a
PS Ratio	541.95
Forward PS	n/a
PB Ratio	1.45
P/FCF Ratio	-4.33
PEG Ratio	0.09

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Icosavax.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.24, with a Debt / Equity ratio of 0.04.

Current Ratio	16.24
Quick Ratio	16.24
Debt / Equity	0.04
Debt / EBITDA	-0.09
Debt / FCF	-0.12
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	$9.7K
Profits Per Employee	$-1.47M
Employee Count	60
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	-3.3M
Effective Tax Rate	3.6%

Stock Price Statistics

The stock price has increased by 0% in the last 52 weeks. The beta is 1.28, so Icosavax's price volatility has been higher than the market average.

Beta	1.28
52-Week Price Change	n/a
50-Day Moving Average	15.45
200-Day Moving Average	10.38
Relative Strength Index (RSI)	55.41
Average Volume (20 Days)	1,053,296

Income Statement

In the last 12 months, Icosavax had revenue of 582K and earned -88.46M in profits. Earnings per share was -2.23.

Revenue	582K
Gross Profit	-1.26M
Operating Income	-95.06M
Net Income	-88.46M
EBITDA	-95.06M
EBIT	-95.06M
Earnings Per Share (EPS)	-2.23

Full Income Statement

Balance Sheet

The company has 58.85M in cash and 8.79M in debt, giving a net cash position of 50.05M.

Cash & Cash Equivalents	58.85M
Total Debt	8.79M
Net Cash	50.05M
Retained Earnings	-185.83M
Total Assets	251.3M
Working Capital	222.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -61.67M and capital expenditures -11.11M, giving a free cash flow of -72.79M.

Operating Cash Flow	-61.67M
Capital Expenditures	-11.11M
Free Cash Flow	-72.79M
FCF Per Share	-1.83

Full Cash Flow Statement

Margins

Gross margin is -216.67%, with operating and profit margins of -16332.99% and -15198.97%.

Gross Margin	-216.67%
Operating Margin	-16332.99%
Pretax Margin	-15765.98%
Profit Margin	-15198.97%
EBITDA Margin	-16332.99%
EBIT Margin	-16332.99%
FCF Margin	-12506.53%

Dividends & Yields

ICVX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for ICVX.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	22.59
Piotroski F-Score	3